These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 26615886)
1. Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent. Zhang L; Chen F; Zhang Z; Chen Y; Wang J Bioorg Med Chem Lett; 2016 Jan; 26(1):38-42. PubMed ID: 26615886 [TBL] [Abstract][Full Text] [Related]
2. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways. Zhang L; Zhang Z; Chen F; Chen Y; Lin Y; Wang J Eur J Med Chem; 2016 Nov; 123():226-235. PubMed ID: 27484511 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activity of dichloroplatinum(II) complexes of podophyllotoxin. Liu X; Zhang LL; Xu XH; Hui L; Zhang JB; Chen SW Bioorg Med Chem Lett; 2013 Jul; 23(13):3780-4. PubMed ID: 23711918 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents. Cheng WH; Cao B; Shang H; Niu C; Zhang LM; Zhang ZH; Tian DL; Zhang S; Chen H; Zou ZM Eur J Med Chem; 2014 Oct; 85():498-507. PubMed ID: 25113878 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel podophyllotoxin-NSAIDs conjugates as multifunctional anti-MDR agents against resistant human hepatocellular carcinoma Bel-7402/5-FU cells. Zhang L; Liu L; Zheng C; Wang Y; Nie X; Shi D; Chen Y; Wei G; Wang J Eur J Med Chem; 2017 May; 131():81-91. PubMed ID: 28301815 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells. Guo YE; Chen H; Zuo S; Liu DL; Lu YL; Lv JJ; Wen SP; Zhang TC J Asian Nat Prod Res; 2011 May; 13(5):417-24. PubMed ID: 21534039 [TBL] [Abstract][Full Text] [Related]
7. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity. Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920 [TBL] [Abstract][Full Text] [Related]
8. One-pot synthesis of podophyllotoxin-thiourea congeners by employing NH₂SO₃H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents. Shankaraiah N; Kumar NP; Amula SB; Nekkanti S; Jeengar MK; Naidu VG; Reddy TS; Kamal A Bioorg Med Chem Lett; 2015 Oct; 25(19):4239-44. PubMed ID: 26292628 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin. Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769 [TBL] [Abstract][Full Text] [Related]
10. One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents. Xu XH; Guan XW; Feng SL; Ma YZ; Chen SW; Hui L Bioorg Med Chem Lett; 2017 Jul; 27(13):2890-2894. PubMed ID: 28512026 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents. Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents. Wu GR; Xu B; Yang YQ; Zhang XY; Fang K; Ma T; Wang H; Xue NN; Chen M; Guo WB; Jia XH; Wang PL; Lei HM Eur J Med Chem; 2018 Jul; 155():183-196. PubMed ID: 29886322 [TBL] [Abstract][Full Text] [Related]
14. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs. Han HW; Qiu HY; Hu C; Sun WX; Yang RW; Qi JL; Wang XM; Lu GH; Yang YH Bioorg Med Chem Lett; 2016 Jul; 26(14):3237-3242. PubMed ID: 27262599 [TBL] [Abstract][Full Text] [Related]
16. CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro. Cao B; Chen H; Gao Y; Niu C; Zhang Y; Li L Int J Mol Med; 2015 Mar; 35(3):771-6. PubMed ID: 25592869 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents. Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents. Wang J; Long L; Chen Y; Xu Y; Zhang L Bioorg Med Chem Lett; 2018 Jun; 28(10):1817-1824. PubMed ID: 29678463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]